Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments.

MLA

Gsottberger, Franziska, et al. “Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments.” International Journal of Molecular Sciences, vol. 22, no. 19, Sept. 2021. EBSCOhost, https://doi.org/10.3390/ijms221910433.

APA

Gsottberger, F., Brandl, C., Wendland, K., Petkovic, S., Emmerich, C., Erber, R., Geppert, C., Hartmann, A., Mackensen, A., Nitschke, L., & Müller, F. (2021). Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments. International Journal of Molecular Sciences, 22(19). https://doi.org/10.3390/ijms221910433

Chicago

Gsottberger, Franziska, Carolin Brandl, Kerstin Wendland, Srdjan Petkovic, Charlotte Emmerich, Ramona Erber, Carol Geppert, et al. 2021. “Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments.” International Journal of Molecular Sciences 22 (19). doi:10.3390/ijms221910433.